首页> 外文会议>International Congress on Coronary Artery Disease >Lumen Centering Versus IVUS-Probe Centering of Gamma Sources: Retrospective Evaluation of Doses to Intima and Adventitia for Intravascular Brachytherapy Cases
【24h】

Lumen Centering Versus IVUS-Probe Centering of Gamma Sources: Retrospective Evaluation of Doses to Intima and Adventitia for Intravascular Brachytherapy Cases

机译:肠势腔与IVUS探针以伽玛来源为中心:对血管内近距离放射治疗病例的内膜和外膜剂量的回顾性评估

获取原文

摘要

Intravascular brachytherapy (IVBT) in the treatment of in-stent restenosis (ISR) using gamma or beta sources delivered at the time of angioplasty has been proven to be effective in preventing restenosis induced by intcrventional recanulazation procedures.1 Long-term follow-up results showed continued benefit of IVBT, with improvement in target lesion revascularization and event-free survival.2 Among the catheter-based systems, some delivery1 catheters are lumen-centered, while others are not. Despite the success of IVBT in treating ISR, the debate regarding the potential benefit of lumen-centering of radioactive sources in the delivery- of IVBT is still ongoing. A common approach of dosimelric evaluation has been based on the assumption that the radioactive sources may be at the center of the IVUS probe in individual image slices. Dosimetric evaluations based on IVUS-probe centered configurations have been reported for Cordis Ir-192 ribbon system.
机译:在血管成形术期间在血管成形术期间递送的γ或β源治疗血管内近距离放射治疗(IVBT)已被证明是有效地防止通过额外重新血统程序引起的再狭窄.1长期随访结果表现出IVBT的持续受益,随着靶病变血运重建和无事实生存的提高.2在基于导管的系统中,一些递送1导管是腔起的,而其他输送的导管不是。尽管IVBT在治疗ISR中取得了成功,但就IVBT交付中的放射源潜在利益的辩论仍在进行。一种常见的剂量评估方法基于假设放射源可以位于各个图像切片中的IVUS探针的中心。据报道了基于IVUS探针为中心配置的剂量测定,用于Cordis IR-192带系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号